Summary Of Bevacizumab-Api-Biologics & Biosimilars

Chemical Name

Bevacizumab

CAS No.

216974-75-3

Molecular Formula

C6538H10034N1716O2033S44

Innovator

Developer

Indication

Colorectal Cancer; Malignant Ascites; Non-Small Cell Lung Cancer

Therapeutic Area

Oncology

Market Status

Launched

Approval Year

Patent Expiry